Products in preclinical development

Click on the product name to link directly to the product sheet.
  Products Indications In Vivo
Testing 		Preclinical
Dev.
Core Early Projects AEZS-115
Non-peptide LHRH antagonists (endocrinology and/or oncology) Multiple cancers, benign prostatic hyperplasia (BPH) and endometriosis		   Preclinical Dev.
AEZS-129, 131 and 132
Erk & PI3K inhibitors (oncology)

To come

 In Vivo Testing  
AEZS-123
Ghrelin receptor antagonist (endocrinology) Obesity and related pathologies		 In Vivo Testing  
Oncology AEZS-120
Prostate cancer vaccine (oncology) Prostate cancer and melanoma		   Preclinical Dev.
AEZS-127
ErPC (oncology) Multiple cancers		   Preclinical Dev.



Contact

To inquire about partnering opportunities (in- or out-licensing), please contact our business development group:

Chantal Gravel
Manager, Business Operations
Phone: (418) 652-8525
cgravel@aezsinc.com

Term and conditions of use. Safe harbor and privacy policy. Copyright © 2004 Æterna Zentaris Inc.
All rights reserved. Use of this site signifies your agreement to the terms of use.